Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00088036
Recruitment Status : Completed
First Posted : July 21, 2004
Last Update Posted : July 24, 2006
Information provided by:
Eli Lilly and Company